Avalo Therapeutics, Inc. (AVTX)
19.26
-0.57
(-2.87%)
USD |
NASDAQ |
Aug 24, 16:00
19.26
0.00 (0.00%)
After-Hours: 20:00
Avalo Therapeutics Total Liabilities (Quarterly) : 42.12M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 42.12M |
| March 31, 2026 | 31.56M |
| December 31, 2025 | 34.65M |
| September 30, 2025 | 33.55M |
| June 30, 2025 | 22.01M |
| March 31, 2025 | 15.91M |
| December 31, 2024 | 17.70M |
| September 30, 2024 | 75.72M |
| June 30, 2024 | 110.46M |
| March 31, 2024 | 224.81M |
| December 31, 2023 | 13.69M |
| September 30, 2023 | 14.58M |
| June 30, 2023 | 31.20M |
| March 31, 2023 | 42.50M |
| December 31, 2022 | 44.28M |
| September 30, 2022 | 38.58M |
| June 30, 2022 | 38.18M |
| March 31, 2022 | 55.56M |
| December 31, 2021 | 57.13M |
| September 30, 2021 | 55.05M |
| June 30, 2021 | 42.50M |
| March 31, 2021 | 30.19M |
| December 31, 2020 | 19.19M |
| Date | Value |
|---|---|
| September 30, 2020 | 20.62M |
| June 30, 2020 | 18.63M |
| March 31, 2020 | 18.53M |
| December 31, 2019 | |
| September 30, 2019 | 38.97M |
| June 30, 2019 | 41.92M |
| March 31, 2019 | 51.75M |
| December 31, 2018 | 49.43M |
| September 30, 2018 | 48.10M |
| June 30, 2018 | 42.93M |
| March 31, 2018 | 40.78M |
| December 31, 2017 | 15.26M |
| September 30, 2017 | 6.083M |
| June 30, 2017 | 2.912M |
| March 31, 2017 | 3.986M |
| December 31, 2016 | 5.562M |
| September 30, 2016 | 8.996M |
| June 30, 2016 | 7.601M |
| March 31, 2016 | 8.048M |
| December 31, 2015 | 8.574M |
| September 30, 2015 | 9.957M |
| June 30, 2015 | 11.43M |
| March 31, 2015 | 10.34M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Incyte Corp. | 1.528B |
| AbbVie, Inc. | 141.00B |
| Rezolute, Inc. | 8.625M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 490.78M |
| Shareholders Equity (Quarterly) | 448.66M |
| Debt to Equity Ratio | 0.005 |
| Current Ratio | 19.31 |
| Net Debt Paydown Yield | 0.01% |